{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:07:21Z","timestamp":1740157641219,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary angioedema (HAE) is an inherited disease characterized by recurrent angioedema without urticaria or pruritus. The most common types of HAE are caused by deficiency or dysfunction in C1 esterase inhibitor (C1-INH-HAE). The association between C1-INH-HAE and systemic lupus erythematosus (SLE) is known; however, variations in the underlying pathophysiology, disease course, and treatment in this population remain incompletely understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 31-year-old Japanese woman with a prior diagnosis of HAE type 1 based on the episodes of recurrent angioedema, low C1 inhibitor antigen levels and function, and family history presented with new complaints of malar rash, alopecia, and arthralgias in her hands and elbows. She later developed fever, oral ulcers, lupus retinopathy, a discoid rash localized to her chest, and malar rash. Investigations revealed positive antinuclear antibody, leukopenia, thrombocytopenia, hypocomplementemia, and nephritis. Based on these findings, she was diagnosed with SLE according to the 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria. There did not appear to be a correlation between HAE disease activity and the timing of presentation with SLE, because HAE disease activity had been stable. The patient was able to achieve and maintain remission with immunosuppressive therapy including prednisolone, hydroxychloroquine, and tacrolimus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our patient presented with a variety of symptoms, including fever and cytopenia in addition to mucocutaneous, joint, ocular, and renal lesions. It is important to better characterize the clinical characteristics of SLE in patients with C1-INH-HAE, and to clarify the mechanisms of SLE in this population.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13223-022-00725-8","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T15:02:21Z","timestamp":1663513341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Yusuke","family":"Ushio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-548X","authenticated-orcid":false,"given":"Risa","family":"Wakiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusaku","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Mahmoud Fahmy","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Mino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Mizusaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1808012","volume":"382","author":"PJ Busse","year":"2020","unstructured":"Busse PJ, Christiansen SC. Hereditary angioedema. N Engl J Med. 2020;382:1136\u201348.","journal-title":"N Engl J Med"},{"key":"725_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12016-016-8553-8","volume":"51","author":"A Reshef","year":"2016","unstructured":"Reshef A, Kidon M, Leibovich I. The story of angioedema: from Quincke to bradykinin. Clin Rev Allergy Immunol. 2016;51:121\u201339.","journal-title":"Clin Rev Allergy Immunol"},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","volume":"161","author":"UC Nzeako","year":"2001","unstructured":"Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417\u201329.","journal-title":"Arch Intern Med"},{"key":"725_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-020-01570-x","volume":"15","author":"K Bork","year":"2020","unstructured":"Bork K, Machnig T, Wulff K, Witzke G, Prusty S, Hardt J. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Orphanet J Rare Dis. 2020;15:289.","journal-title":"Orphanet J Rare Dis"},{"key":"725_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","volume":"359","author":"BL Zuraw","year":"2008","unstructured":"Zuraw BL. Clinical practice Hereditary angioedema. N Engl J Med. 2008;359:1027\u201336.","journal-title":"N Engl J Med"},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/0091-6749(86)90425-2","volume":"77","author":"CM Brickman","year":"1986","unstructured":"Brickman CM, Tsokos GC, Chused TM, Balow JE, Lawley TJ, Santaella M, et al. Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. J Allergy Clin Immunol. 1986;77:758\u201367.","journal-title":"J Allergy Clin Immunol"},{"key":"725_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02871792","volume":"19","author":"L Fontana","year":"1989","unstructured":"Fontana L, Perricone R, De Carolis C, Pizzolo JG, Casciani CU. Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects. Ric Clin Lab. 1989;19:51\u20138.","journal-title":"Ric Clin Lab"},{"key":"725_CR8","first-page":"259","volume":"31","author":"B Hory","year":"1989","unstructured":"Hory B, Haultier JJ. Glomerulonephritis and hereditary angioedema: report of 2 cases. Clin Nephrol. 1989;31:259\u201363.","journal-title":"Clin Nephrol"},{"key":"725_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","volume":"71","author":"A Agostoni","year":"1992","unstructured":"Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Med (Baltimore). 1992;71:206\u201315.","journal-title":"Med (Baltimore)"},{"key":"725_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2006.09.015","volume":"123","author":"S Khan","year":"2007","unstructured":"Khan S, Tarzi MD, Dore PC, Sewell WAC, Longhurst HJ. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin Immunol. 2007;123:14\u20137.","journal-title":"Clin Immunol"},{"key":"725_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2011.05.004","volume":"141","author":"H Farkas","year":"2011","unstructured":"Farkas H, Csuka D, G\u00e1cs J, Czaller I, Zotter Z, F\u00fcst G, et al. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Clin Immunol. 2011;141:58\u201366.","journal-title":"Clin Immunol"},{"key":"725_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2249.2011.04527.x","volume":"167","author":"A Kessel","year":"2012","unstructured":"Kessel A, Peri R, Perricone R, Guarino MD, Vadasz Z, Novak R, et al. The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Clin Exp Immunol. 2012;167:422\u20138.","journal-title":"Clin Exp Immunol"},{"key":"725_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1346-8138.2002.tb00316.x","volume":"29","author":"M Koide","year":"2002","unstructured":"Koide M, Shirahama S, Tokura Y, Takigawa M, Hayakawa M, Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J Dermatol. 2002;29:503\u20137.","journal-title":"J Dermatol"},{"key":"725_CR14","first-page":"622","volume":"16","author":"P Triggianese","year":"2014","unstructured":"Triggianese P, Guarino MD, Ballanti E, Chimenti MS, Perricone R. Hereditary angioedema and autoimmunity. Isr Med Assoc J. 2014;16:622\u20134.","journal-title":"Isr Med Assoc J"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.autrev.2015.02.001","volume":"14","author":"IG S\u00e9r\u00e9zal","year":"2015","unstructured":"S\u00e9r\u00e9zal IG, Bouillet L, Dh\u00f4te R, Gayet S, Jeandel PY, Blanchard-Delaunay C, et al. Hereditary angioedema and lupus: a French retrospective study and literature review. Autoimmun Rev. 2015;14:564\u20138.","journal-title":"Autoimmun Rev"},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13223-020-00437-x","volume":"16","author":"D Levy","year":"2020","unstructured":"Levy D, Craig T, Keith PK, Krishnarajah G, Beckerman R, Prusty S. Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review. Allergy Asthma Clin Immunol. 2020;16:41.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"725_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13223-020-00439-9","volume":"16","author":"H Farkas","year":"2020","unstructured":"Farkas H, Levy D, Supina D, Berger M, Prusty S, Fridman M. Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database. Allergy Asthma Clin Immunol. 2020;16:42.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"725_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Kamen DL, et al. 2019 European League Against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11:754\u201365.","journal-title":"Autoimmun Rev"},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0961203309357059","volume":"19","author":"T M\u00e9sz\u00e1ros","year":"2010","unstructured":"M\u00e9sz\u00e1ros T, F\u00fcst G, Farkas H, Jakab L, Temesszentandr\u00e1si G, Nagy G, et al. C1-inhibitor autoantibodies in SLE. Lupus. 2010;19:634\u20138.","journal-title":"Lupus"},{"key":"725_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.alit.2018.03.002","volume":"67","author":"A Fukunaga","year":"2018","unstructured":"Fukunaga A, Tsuchiyama S, Lee K, Washio K, Hashimura C, Horiuchi T, et al. The relationship between complement levels and disease activity in Japanese family cases of hereditary angioedema with C1-INH deficiency. Allergol Int. 2018;67:518\u201320.","journal-title":"Allergol Int"},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.autrev.2013.11.007","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, et al. Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev. 2014;13:621\u20139.","journal-title":"Autoimmun Rev"},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler ME, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"725_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10067-013-2227-1","volume":"32","author":"S Vilaiyuk","year":"2013","unstructured":"Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol. 2013;32:899\u2013904.","journal-title":"Clin Rheumatol"},{"key":"725_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI106116","volume":"48","author":"CB Carpenter","year":"1969","unstructured":"Carpenter CB, Ruddy S, Shehadeh IH, M\u00fcller-Eberhard HJ, Merrill JP, Austen KF. Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE). J Clin Invest. 1969;48:1495\u2013505.","journal-title":"J Clin Invest"},{"key":"725_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1160\/TH10-04-0252","volume":"104","author":"AE Davis 3rd","year":"2010","unstructured":"Davis AE 3rd, Lu F, Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost. 2010;104:886\u201393.","journal-title":"Thromb Haemost"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"725_CR29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.157.2.549","volume":"157","author":"MB Fischer","year":"1996","unstructured":"Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol. 1996;157:549\u201356.","journal-title":"J Immunol"},{"key":"725_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/08916930701510673","volume":"40","author":"L Truedsson","year":"2007","unstructured":"Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007;40:560\u20136.","journal-title":"Autoimmunity"},{"key":"725_CR31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12:716\u201330.","journal-title":"Nat Rev Rheumatol"},{"key":"725_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00002281-200301000-00010","volume":"15","author":"M-L Barilla-LaBarca","year":"2003","unstructured":"Barilla-LaBarca M-L, Atkinson JP. Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol. 2003;15:55\u201360.","journal-title":"Curr Opin Rheumatol"},{"key":"725_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","volume":"7","author":"ACL Macedo","year":"2016","unstructured":"Macedo ACL, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7:55.","journal-title":"Front Immunol"},{"key":"725_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","volume":"376","author":"H Longhurst","year":"2017","unstructured":"Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, et al. Prevention of hereditary angioedema attacks with a subcutaneous C1 Inhibitor. N Engl J Med. 2017;376:1131\u201340.","journal-title":"N Engl J Med"},{"key":"725_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jaip.2019.01.054","volume":"7","author":"T Craig","year":"2019","unstructured":"Craig T, Zuraw B, Longhurst H, Cicardi M, Bork K, Grattan C, et al. Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2019;7:1793\u2013802.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-022-00725-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T13:37:48Z","timestamp":1676813868000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-022-00725-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1186\/s13223-022-00725-8","relation":{},"ISSN":["1710-1492"],"issn-type":[{"type":"electronic","value":"1710-1492"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"We obtained the patients\u2019 written consent prior for the purpose of publication of case details and images prior to submitting this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}